Back to search

Article

The Role of Secondary Cytoreductive Surgery in Primary Platinum-sensitive Recurrent HGSOC Patients With Different BRCA1/2 Mutation Status: a Retrospective Study

2021-03-22

Abstract excerpt

<h4>Background: </h4> The value of secondary cytoreductive surgery (SCS) for platinum-sensitive recurrent high grade serous ovarian cancer (HGSOC) patients and the effect s of BRCA1/2 mutation status on the value of surgery are inconclusive. <h4>Methods: </h4>: A retrospective analysis was conducted in HGSOC patients with primary platinum-sensitive recurrence who were admitted to the Department of Obstetrics and G...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7ec30c4c-20e0-5cf6-822b-c5d4e44936be
DOI
10.21203/rs.3.rs-335244/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Role of Secondary Cytoreductive Surgery in Primary Platinum-sensitive Recurrent HGSOC&nbsp;Patients With Different BRCA1/2&nbsp;Mutation Status: a Retrospective StudyDOI 10.21203/rs.3.rs-335244/v1
Germline BRCA mutation carriers are more likely to undergo cytoreductive surgery for relapsed, platinum sensitive, ovarian cancer.Semantic proximity
Platinum-Based Chemotherapy Versus Secondary Cytoreductive Surgery Before Olaparib Maintenance Therapy for 259 Patients with BRCA Mutated Platinum-Sensitive Recurrent Ovarian Cancer: A Multicenter Retrospective Study: Comparative Effectiveness and Survival Outcomes Analysis.Semantic proximity
Impact of Neoadjuvant Chemotherapy on Somatic Mutation Status in High-grade Serous Ovarian CarcinomaSemantic proximity
Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis.Semantic proximity
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma.Semantic proximity
Effects of neoadjuvant chemotherapy in ovarian cancer patients with different germline BRCA1/2 mutational status: A retrospective studySemantic proximity
Effect of BRCA mutational status on survival outcome in advanced-stage high-grade serous ovarian cancerSemantic proximity
Genetic characteristics of platinum-sensitive ovarian clear cell carcinomaSemantic proximity
Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer.Semantic proximity
Construction and Validation of a Platinum Sensitivity Predictive Model With Multiple Genomic Variations for Epithelial Ovarian CancerSemantic proximity
Comparison of Survival Outcomes According to BRCA1/2 Variant Type in High-grade Serous Ovarian Cancer.Semantic proximity
The genomic landscape of recurrent ovarian high grade serous carcinoma: the BriTROC-1 studySemantic proximity
Select a neighboring publication to make it the new centre.